Retinoblastoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Clinical Trials
• Forums

Ocular Conservative Treatment for Retinoblastoma : Efficacy of the New Management Strategies and Visual Outcome
Condition:   Retinoblastoma Interventions:   Drug: Melphalan or Melphalan + Topotecan;   Drug: etoposide, carboplatin and vincristine;   Drug: Carboplatin administered on Day 1;   Device: Thermotherapy (local treatment);   Device: Cryotherapy (local treatment);   Device: Iodine-125 plaques (local treatment);   Drug: Intravitreal Melphalan chemotherapy injections (local treatment) Sponsors:   Institut Curie;   Fondation Rothschild Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 23, 2020 Category: Research Source Type: clinical trials